GlassScriptPhysician profile
Thomas L Abell
NPI 1174567382
$35,532.37
in general payments reported to CMS, 2019-2025
13 companies · $2,321 in 2025
The $2,321 reported for 2025 was more than what 82% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $14.54 · 2021: $1,559 · 2022: $11K · 2023: $8,183 · 2024: $12K · 2025: $2,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Consulting Fee: $10K · Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,000.00 |
| Consulting Fee | $10,200.00 |
| Food and Beverage | $733.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $33,633.97 | 2022-2025 | |
| Medtronic, INC. | $1,522.95 | 2021 | |
| Medtronic USA, INC. | $160.00 | 2019 | |
| Abbott Laboratories | $142.83 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.58 | 2019 | |
| Allergan, INC. | $18.37 | 2021 | |
| Conmed Corporation | $18.13 | 2021 | |
| Merck Sharp & Dohme LLC | $14.54 | 2020 |
5 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Abell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.